Scholarlink

<p>In addition to its role in hemostasis, Factor VIII (FVIII) has recently been shown to potentially impact angiogenesis, inflammation, osteopenia, and sarcopenia. This was explored here by studying the musculoskeletal development of FVIII knockout (<i>FVIII</i><sup><i>-/-</i></sup>) male mice. These animals developed an osteoporotic phenotype with significant bone microarchitectural alteration, reduced vascularization, and a lower osteoblastic population. Proteomic analyses revealed differentiating bone metabolism-related proteins between <i>FVIII</i><sup><i>-/-</i></sup> and wildtype mice. Weekly infusions of recombinant FVIII protein reversed this phenotype. Surprisingly, younger <i>FVIII</i><sup><i>-/-</i></sup> mice had heavier muscles with larger fibers, shifted from type IIx to type IIb, not reversed by FVIII treatment. Significant proteomic and metabolomic differences between wildtype and <i>FVIII</i><sup><i>-/-</i></sup> muscles were observed, some of which were reduced by FVIII treatment. This study provides the first comprehensive full-phenotypic characterization of bones and muscles in <i>FVIII</i><sup><i>-/-</i></sup> mice and demonstrates the benefits of FVIII supplementation to normalize their musculoskeletal phenotype.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Factor VIII restores bone parameters and modulates muscle proteo-metabolome in Factor VIII knockout male mice

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月11日

查看全文
  • Antoine Babuty,
  • Javier Muñoz-Garcia,
  • Olivier D. Christophe,
  • Laurie Fradet,
  • Manon Taupin,
  • Denis Cochonneau,
  • Emilie Ollivier,
  • Frank Driessler,
  • Claudia Lange,
  • Oleksandr Boychenko,
  • Marie-Françoise Heymann,
  • Dominique Heymann

摘要

In addition to its role in hemostasis, Factor VIII (FVIII) has recently been shown to potentially impact angiogenesis, inflammation, osteopenia, and sarcopenia. This was explored here by studying the musculoskeletal development of FVIII knockout (FVIII-/-) male mice. These animals developed an osteoporotic phenotype with significant bone microarchitectural alteration, reduced vascularization, and a lower osteoblastic population. Proteomic analyses revealed differentiating bone metabolism-related proteins between FVIII-/- and wildtype mice. Weekly infusions of recombinant FVIII protein reversed this phenotype. Surprisingly, younger FVIII-/- mice had heavier muscles with larger fibers, shifted from type IIx to type IIb, not reversed by FVIII treatment. Significant proteomic and metabolomic differences between wildtype and FVIII-/- muscles were observed, some of which were reduced by FVIII treatment. This study provides the first comprehensive full-phenotypic characterization of bones and muscles in FVIII-/- mice and demonstrates the benefits of FVIII supplementation to normalize their musculoskeletal phenotype.